Your browser doesn't support javascript.
loading
A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study).
Ang, Yvonne L E; Zhao, Xiaotian; Reungwetwattana, Thanyanan; Cho, Byoung-Chul; Liao, Bin-Chi; Yeung, Rebecca; Loong, Herbert H; Kim, Dong-Wan; Yang, James Chih-Hsin; Lim, Sun Min; Ahn, Myung-Ju; Lee, Se-Hoon; Suwatanapongched, Thitiporn; Kongchauy, Kanchaporn; Ou, Qiuxiang; Yu, Ruoying; Tai, Bee Choo; Goh, Boon Cher; Mok, Tony S K; Soo, Ross A.
Afiliação
  • Ang YLE; Department of Haematology-Oncology, National University Cancer Institute, Singapore 119074, Singapore.
  • Zhao X; Geneseeq Research Institute, Geneseeq Technology Inc., Nanjing 210032, China.
  • Reungwetwattana T; Division of Medical Oncology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
  • Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Liao BC; Department of Oncology, National Taiwan University Hospital, Taipei 100229, Taiwan.
  • Yeung R; National Taiwan University Cancer Center, Taipei 100229, Taiwan.
  • Loong HH; Clinical Oncology Department, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.
  • Kim DW; Department of Clinical Oncology, The Chinese University of Hong Kong, Central Ave, Hong Kong.
  • Yang JC; Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.
  • Lim SM; Department of Oncology, National Taiwan University Hospital, Taipei 100229, Taiwan.
  • Ahn MJ; National Taiwan University Cancer Center, Taipei 100229, Taiwan.
  • Lee SH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Suwatanapongched T; Division of Haematology-Oncology, Samsung Medical Center, Seoul 06351, Republic of Korea.
  • Kongchauy K; Division of Haematology-Oncology, Samsung Medical Center, Seoul 06351, Republic of Korea.
  • Ou Q; Division of Diagnostic Radiology, Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
  • Yu R; Clinical Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
  • Tai BC; Geneseeq Research Institute, Geneseeq Technology Inc., Nanjing 210032, China.
  • Goh BC; Geneseeq Research Institute, Geneseeq Technology Inc., Nanjing 210032, China.
  • Mok TSK; Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117549, Singapore.
  • Soo RA; Department of Haematology-Oncology, National University Cancer Institute, Singapore 119074, Singapore.
Cancers (Basel) ; 15(20)2023 Oct 16.
Article em En | MEDLINE | ID: mdl-37894366

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article